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of syrupAbstract The study describes the development, validation and application of a simple and reliable
HPLC-DAD procedure for the stability-indicating determination of the cough suppressant drug
pentoxyverine citrate (PTV). The method involved the use of Waters Symmetry C8
(3.9 · 150 mm, 5 lm) column with gradient elution of the mobile phase composed of 0.025 M phos-
phoric acid and acetonitrile. The gradient elution started with 10% (by volume) acetonitrile,
ramped up linearly to 60% in 10 min then it was kept constant till the end of the run. The mobile
phase was pumped at a ﬂow rate of 1 mL/min. The multiple wavelength detector was set at 210 nm,
and quantiﬁcation of the analyte was based on measuring its peak area. Retention time for PTV was
about 7.03 min. Reliability and analytical performance of the proposed HPLC method was vali-
dated with respect to linearity, range, precision, accuracy, speciﬁcity, robustness, detection and
quantiﬁcation limits. Calibration curve of PTV was linear in the range 10–150 lg/mL with correla-
tion coefﬁcient >0.9998. The drug was subjected to forced-degradation conditions of hydrolysis,
oxidation and dry heat. The proposed method proved to be speciﬁc and stability-indicating by res-
olution of the drug from its forced-degradation products. The validated HPLC method was applied
to the analysis of PTV in syrup form where it was successfully resolved from the pharmaceutical
additives and quantiﬁed with recoveries not less than 97.7%. Moreover, the proposed method
was utilized to investigate the kinetics of acidic and basic hydrolysis of PTV, and to derive its
pH-rate of degradation proﬁle in Britton–Robinson buffer within the pH range 2–12. Finally,
the proposed method made use of DAD as a tool for peak identity and purity conﬁrmation.
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T.S. Belal).
Saud University.
g by Elsevier
. Production and hosting by Elsev
1.023
, D.A., Belal, T.S. HPLC-DAD sta
dosage form. Arabian Journal of1. Introduction
Pentoxyverine citrate (PTV; also known as carbetapentane citrate)
(Fig. 1), chemically known as 2-[2-(diethylamino)ethoxy]ethyl 1-
phenylcyclopentanecarboxylate dihydrogen 2-hydroxypropane-
1,2,3-tricarboxylate (The British Pharmacopoeia, 2010), is aier B.V. All rights reserved.
bility indicating determination of pentoxyverine citrate. Application to
Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.11.023
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Figure 1 Chemical structure of pentoxyverine citrate (PTV).
2 D.A. Gawad, T.S. Belalcentrally acting cough suppressant used for non-productive cough
(Sweetman, 2009). Themonograph of PTV in the British Pharma-
copoeia (BP) describes a potentiometric non-aqueous titration
procedure for analysis of the bulk powder (The British Pharmaco-
poeia, 2010), however no ofﬁcial methods can be found for assay
of the drug in dosage forms.
The quantiﬁcation of PTV in pharmaceutical preparations
and/or biological samples was addressed in various reports.
Analytical methods in these reports involved the use of color-
imetry (Lin and Xie, 1984; Weclawska and Regosz, 1987),
derivative spectrophotometry (Lin et al., 1992; Wen, 2000),
ﬂow-injection chemiluminescence (Zhang et al., 2009) and dif-
ferent sensors and electrodes based on ion-pair complexes
(Hopkala et al., 1994; Yin, 2004). Also, the scientiﬁc literature
showed the use of separation techniques such as capillary elec-
trophoresis with electrochemiluminescence detection (Liu
et al., 2005), HPLC–UV detection (Gad-Kariem and Abounas-
sif, 1997; Jiang et al., 2008) and LC–MS for the determination
of PTV in human plasma (Yu et al., 2009; Wen et al., 2010).
Recently, HPLC-DAD was applied for the determination of
syrups containing PTV in combination with other drugs (Do¨n-
mez et al., 2011). Finally, characterization of PTV and its
metabolites in urine was carried out using GC–MS (Westphal
et al., 2012). To the best of our knowledge, no reports have
been published yet dealing with the forced degradation of
PTV or its stability indicating assay in a complex pharmaceu-
tical dosage form such as the syrup form.
The aim of the present study is the development, validation,
and application of a simple, reliable and speciﬁc HPLC-DAD
method for the analysis of PTV in syrup dosage form. The
method was thoroughly tested for its speciﬁcity and stability-
indicating properties by resolution of the drug from its forced
hydrolytic, oxidative, and dry heat degradation products. The
developed HPLC method was also applied to study the kinet-
ics of acidic and basic hydrolysis of PTV. Pseudo-ﬁrst order
rate constants and half-lives were calculated in each case. In
addition, the Arrhenius plot was used to predict the shelf sta-
bility of PTV in acidic solutions at room temperature, and pH-
rate proﬁle of PTV degradation in Britton–Robinson buffer
solutions was investigated.
2. Experimental
2.1. Instrumentation
The HPLC-DAD system consisted of Agilent 1200 series (Agi-
lent Technologies, Santa Clara, CA, USA) (quaternary pump,
vacuum degasser and diode array and multiple wavelength
detector G1315 C/D and G1365 C/D) connected to a computer
loaded with Agilent ChemStation Software. A RheodynePlease cite this article in press as: Gawad, D.A., Belal, T.S. HPLC-DAD sta
degradation kinetics and assay of syrup dosage form. Arabian Journal ofmanual injector with 20 lL loop was used. The column used
was Waters Symmetry C8 (3.9 · 150 mm, 5 lm particle size).
2.2. Materials
Pentoxyverine citrate was kindly supplied by Borg Pharmaceu-
tical Industries Co., Alexandria, Egypt. HPLC-grade acetoni-
trile (Scharlau Chemie S.A., Sentmenat, Spain), HPLC-grade
methanol (Fisher Scientiﬁc UK Limited, Loughborough,
Leicestershire, UK), analytical grade of ortho-phosphoric acid,
hydrochloric acid, sodium hydroxide, 50% hydrogen peroxide,
glacial acetic acid, boric acid and high purity distilled water
were used. The pharmaceutical preparation assayed in the
study is Cabella syrup (Borg Pharmaceutical Industries
Co., Alexandria, Egypt, BN 034015) labeled to contain
21.3 mg pentoxyverine citrate in each 10 mL syrup.
2.3. General procedure
A gradient mobile phase system consisting of (A) 0.025 M
phosphoric acid and (B) acetonitrile was used. The separation
was achieved with a linear gradient program as follows: 10%
v/v B at zero time; from 0 to 10 min, ramp up to 60% v/v B;
from 10 to 15 min, holding 60% v/v B. After 15 min, the gra-
dient program was returned to the initial conditions and the
analytical column was reconditioned for 3 min. The ﬂow rate
was 1.0 mL/min. The injection volume was 20 lL. The eluant
was monitored by the diode array detector from 190 to
400 nm, and chromatograms were extracted at 210 nm. All
determinations were performed at 25 C.
PTV stock solution (1000 lg/mL) was prepared in HPLC-
grade methanol. The working solutions were prepared by dilu-
tion of the stock solutions with distilled water to reach the con-
centration range 10–150 lg/mL PTV, respectively. Triplicate
injections were made for each concentration and chromato-
graphed under the previously described LC conditions. The
peak areas were plotted against the corresponding concentra-
tions to construct the calibration graphs.
2.4. Assay of syrup dosage form
Accurate volumes of Cabella syrup were diluted with dis-
tilled water to obtain ﬁnal concentrations within the analytical
range of PTV (10–150 lg/mL) then treated as under General
Procedure. Recovery values were calculated from similarly
treated standard solutions. For standard addition assay, sam-
ple solutions were spiked with aliquots of PTV standard solu-
tion to obtain total concentrations within the previously
speciﬁed range then treated as under the general procedure.
Recovered concentrations were calculated by comparing the
analyte response with the increment response attained after
addition of the standard.
2.5. Forced degradation and stability-indicating study
Forced degradation studies were carried out on the PTV stan-
dard as well as its commercial syrup dosage form according to
the following conditions:bility indicating determination of pentoxyverine citrate. Application to
Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.11.023
HPLC-DAD stability indicating determination of pentoxyverine citrate 3(a) Acidic and basic conditions: PTV solution was treated
with 1 mL of 1 M HCl or 1 M NaOH. The acidic degra-
dation solution was placed in a water bath at 100 C for
1 h, while the solution in NaOH was kept at room tem-
perature for 1 h. After the speciﬁed time, all solutions
were neutralized by adjusting the pH to 7.0 and then
diluted with distilled water to reach a ﬁnal concentration
of 75 lg/mL of PTV. The same procedure was applied to
an aliquot of the syrup dosage form.
(b) Oxidation with H2O2: PTV solution was treated with
0.5 mL of hydrogen peroxide 5%. The solution was
placed in a water bath at 80 C for 1 h. After the speci-
ﬁed time, the solution was diluted with distilled water to
reach a ﬁnal concentration of 75 lg/mL PTV. An ali-
quot of the syrup dosage form was similarly treated.
(c) Dry heat degradation: An amount of PTV powder
(50 mg) was kept in an oven at 90 C for 12 h. After
the speciﬁed time, the powder was dissolved in metha-
nol, and aliquots of this methanolic stock were diluted
with distilled water to reach a ﬁnal concentration of
75 lg/mL PTV.
After the previous treatments, solutions were ﬁltered with a
0.45 lm ﬁltration disk prior to injection to the column.
2.6. Kinetics study
2.6.1. Acidic hydrolysis
Accurate volumes of PTV stock solution giving ﬁnal concen-
tration of 75 lg/mL were transferred into a series of glass tubes
and mixed with 1-mL volumes of 1 M HCl. The tubes were
heated at different temperatures (70, 80 and 100 C). At the
speciﬁed time intervals, the contents of the tubes were neutral-
ized to pH 7.0 using predetermined volumes of 1 M NaOH.
2.6.2. Basic hydrolysis
Basic hydrolysis of PTV was carried out at room temperature.
Aliquots of PTV stock solution giving ﬁnal concentration of
75 lg/mL were separately mixed with 1-mL volumes of (0.1,
0.5 and 1.0 M) NaOH solutions. In each case, the solutions
were left at room temperature for different time intervals.
The contents of each ﬂask were then separately neutralized
with predetermined volumes of 1 M HCl solution.
2.6.3. pH-rate proﬁle
Accurate volumes of PTV stock solution giving ﬁnal concen-
tration of 75 lg/mL were transferred into a series of glass tubes
and mixed with 2-mL volumes of Britton–Robinson buffer
solutions. The pH values used for measurement of the pH-rate
proﬁle of the degradation of PTV are within pH 2–12 in one
unit pH intervals. The tubes were placed in a water bath at
100 C for different time intervals, and then the contents of
each tube were neutralized using 1 M NaOH or 1 M HCl.
For all the above kinetic study solutions, the neutralized
solutions were then quantitatively transferred to a series of
10 mL volumetric ﬂasks and appropriately diluted to volume
with water. The solutions thus prepared were analyzed as de-
scribed under general procedure. The concentration of the
remaining PTV was calculated at each temperature and time
interval. Data were further processed and degradation kinetics
constants were calculated.Please cite this article in press as: Gawad, D.A., Belal, T.S. HPLC-DAD sta
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3.1. Optimization of chromatographic conditions
A gradient liquid chromatographic method coupled with diode
array detection was developed to provide a suitable procedure
for the routine quality control analysis of PTV in its complex
syrup dosage form. The most important aspect in LC method
development is the achievement of sufﬁcient resolution of the
target drug from all other compounds present in the sample
with acceptable peak symmetry in a reasonable analysis time.
To achieve this goal, several experiments were carried out in
order to optimize both the stationary and mobile phases.
For optimization of the stationary phase, several reversed
phase columns (Zorbax SB-C8 (4.6 · 250 mm), Zorbax SB-
C18 (4.6 · 250 mm), Zorbax Eclipse XDB-C18
(4.6 · 150 mm), Waters Symmetry C18 (3.9 · 150 mm) and
Waters Symmetry C8 (3.9 · 150 mm)) were tested. The best
clear separation between the eluting peaks, sharper symmetric
PTV peak and relatively shorter retention time were attained
by using the Waters Symmetry C8 column; hence, it became
the column of choice for this study. Other columns especially
those of 250 mm length resulted in longer retention times for
the eluting peaks and broader PTV peak.
The mobile phase composition was evaluated using various
proportions of 0.025 M phosphoric acid solution and acetoni-
trile. Gradient elution was found necessary in order to ensure
complete separation between PTV and all other substances in
the analyzed samples (forced degradation products or inactive
constituents of the syrup dosage form) in a reasonable run time
and acceptable peak shape. The best chosen gradient program
started with 10% (by volume) acetonitrile ramped up linearly
to 60% in 10 min then kept at this percentage afterward. Flow
rate was kept constant at 1.0 mL/min all over the run, and
temperature was adjusted at 25 C. It is noteworthy to mention
that the applied gradient program produced stable baseline
without any drift or deformation.
Quantiﬁcation was achieved using diode array detection
based on peak area measurement. PTV is considered a weak
UV absorbing compound. It exhibits considerable absorbance
only in the short UV region (below 230 nm); consequently,
210 nm was found suitable to record all chromatograms in this
study. The above described chromatographic conditions
showed symmetric PTV peaks with good system suitability
parameters. Fig. 2A shows a typical chromatogram for stan-
dard PTV. The drug elutes at retention time
7.03 ± 0.056 min with retention factor (k) = 3.18. The col-
umn performance (apparent efﬁciency) can be expressed by
the number of theoretical plates (N) for the analyte peak which
equals about 63780.
3.2. Validation of the proposed method
3.2.1. Linearity and concentration range
The linearity of the proposed HPLC procedure was evalu-
ated by analyzing a series of different concentrations of
PTV (n= 7) (Fig. 3). The linear regression equation was
generated by least squares treatment of the calibration data.
Under the optimized conditions described above, the mea-
sured peak areas were found to be proportional to concen-
trations of the analyte. Table 1 presents the performancebility indicating determination of pentoxyverine citrate. Application to
Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.11.023
4 D.A. Gawad, T.S. Belaldata and statistical parameters including linear regression
equation, concentration range, correlation coefﬁcient, stan-
dard deviations of the intercept (Sa), slope (Sb) and stan-
dard deviations of residuals (Sy/x). Regression analysis
shows good linearity as indicated from the correlation coef-
ﬁcient value (0.9998). In addition, deviation around the
slope can be further evaluated by calculation of the
RSD% of the slope (Sb%) which was found to be less than
1.0%. The analysis of variance test for the regression line
reveals that, for equal degrees of freedom, an increase in
the variance ratio (F values) means an increase in the mean
of squares due to regression and a decrease in the mean of
squares due to residuals. The greater the mean of squares
due to regression, the steeper is the regression line. The
smaller the mean of squares due to residuals, the less is
the scatter of experimental points around the regression
line. Consequently, regression lines with high F values
(low signiﬁcance F) are much better than those with lower
ones (Table 1).0 1 2 3 4
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Figure 2 HPLC chromatogram of 20 lL injection of 75 lg/mL stan
PTV after exposure to acid degradation (1 M HCl/100 C for 1 h) (B)
degradation (5% H2O2/80 C for 1 h) (D) and dry heat degradation (
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According to the pharmacopoeial recommendations (The Uni-
ted States Pharmacopeia, 2011), limit of detection (LOD) and
quantiﬁcation (LOQ) were determined, at signal to noise ratios
of 3:1 and 10:1, respectively (Table 1). The LOQ value (7.6 lg/
mL) was veriﬁed by its nearness to the lower concentration of
the working range.
3.2.3. Precision and accuracy
The within-day (intra-day) precision and accuracy for the pro-
posed method were studied at three concentration levels of
PTV using three replicate determinations for each concentra-
tion within one day. Similarly, the between-day (inter-day) pre-
cision and accuracy were tested by analyzing the same three
concentrations using three replicate determinations repeated
on three days. Recoveries were calculated using the corre-
sponding regression equations and they were satisfactory.
The percentage relative standard deviation (RSD%) andmin5 6 7 8 9
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90 C for 12 h) (E).
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Fig. 2 (continued)
HPLC-DAD stability indicating determination of pentoxyverine citrate 5percentage relative error (Er%) were less than 1.5% proving
the high repeatability, intermediate precision and accuracy of
the developed method for the estimation of PTV in bulk form
(Table 2).Please cite this article in press as: Gawad, D.A., Belal, T.S. HPLC-DAD sta
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Speciﬁcity is deﬁned as the ability to access unequivocally the
analyte in the presence of components that may be expected to
be present, such as impurities, degradation products andbility indicating determination of pentoxyverine citrate. Application to
Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.11.023
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Figure 3 3-Dimentional plot of HPLC chromatograms of serial concentrations of standard PTV: 10, 20, 40, 60, 80, 100 and 150 lg/mL.
6 D.A. Gawad, T.S. Belalmatrix components (The United States Pharmacopeia, 2011),
and this will be demonstrated in detail in the following sections
of this study.Table 1 Analytical parameters for the determination of PTV
using the proposed HPLC-DAD method.
Parameter PTV
Wavelength (nm) 210
Linearity range (lg/mL) 10–150
Intercept (a) 2.30
Sa
a 12.42
Slope (b) 20.72
Sb
b 0.16
RSD% of the slope 0.77
Correlation coeﬃcient (r) 0.99986
Sy/x
c 18.66
Fd 17721
Signiﬁcance F 4.54 · 1010
LODe (lg/mL) 2.28
LOQf (lg/mL) 7.60
a Standard deviation of the intercept.
b Standard deviation of the slope.
c Standard deviation of residuals.
d F Equals the mean of squares due to regression divided by the
mean of squares about regression (due to residuals).
e Limit of detection.
f Limit of quantiﬁcation.
Table 2 Precision and accuracy for the determination of PTV usin
Nominal value (lg/mL) Foun
Within-day 10 9.9
40 40.1
100 100.4
Between-day 10 9.9
40 40.3
100 101.2
a Mean ± standard deviation for three determinations.
b % Relative standard deviation.
c % Relative error.
Please cite this article in press as: Gawad, D.A., Belal, T.S. HPLC-DAD sta
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The robustness of an analytical procedure is a measure of its
capacity to remain unaffected by small but deliberate varia-
tions in procedural parameters (The United States Pharmaco-
peia, 2011). Robustness was examined by evaluating the
inﬂuence of small variations in different conditions such as
source of acetonitrile (Scharlau Chemie S.A., Spain or SDS,
France or Labscan, Poland), working wavelength (±2 nm),
ﬂow rate (±0.05 mL/min) and column temperature (±2 C).
These variations did not have any signiﬁcant effect on the mea-
sured responses or the chromatographic resolution. RSD% for
the measured peak areas using these variations did not exceed
3%.
3.2.6. Stability of solutions
The stability of standard working solutions as well as sample
solutions in the diluting solvent (distilled water) was examined
and no chromatographic changes were observed within 24 h at
room temperature. Also, the stock solutions prepared in
HPLC-grade methanol were stable for at least one week when
stored refrigerated at 4 C. Retention time and peak area of
PTV remained unchanged and no degradation could be ob-
served during these periods.
3.3. Analysis of syrup dosage form
The optimized HPLC-DAD procedure was applied for the as-
say of PTV in the pharmaceutical formulation available in theg the proposed HPLC-DAD method.
d ± SDa (lg/mL) RSDb (%) Er
c (%)
1 ± 0.08 0.81 0.90
6 ± 0.28 0.70 0.40
4 ± 0.83 0.83 0.44
3 ± 0.12 1.21 0.70
8 ± 0.41 1.02 0.95
2 ± 1.28 1.27 1.22
bility indicating determination of pentoxyverine citrate. Application to
Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.11.023
HPLC-DAD stability indicating determination of pentoxyverine citrate 7local market (Cabella syrup). Accurate volumes of the syrup
were diluted with distilled water to reach the concentration
range of PTV (10–150 lg/mL) then solutions were injected to
the column. A representative chromatogram obtained from
the syrup sample solution is shown in Fig. 4A. PTV eluted
at its speciﬁc retention time, and the inactive ingredients of
the formulation appeared as well-resolved peaks at retention
times 5.37 min (saccharin sodium), 7.43 min (methyl paraben)
and 10.10 min (propyl paraben). Resolution (Rs) is a measure
of the degree of separation between adjacent peaks. A resolu-
tion value of 1.5 is usually regarded as sufﬁcient for the base-
line separation of closely eluted peaks (Kazakevich and
Lobrutto, 2007). Resolution (Rs) was calculated between
PTV and its nearest peak at 7.43 min, and it was found to be
4.41. Additionally, resolution was found to be 9.84 between
PTV and the preceding peak at 5.37 min. The diode-array
detector enables peak purity veriﬁcation of the analyte where
no signs of co-elution from any of the inactive components
were detected. Recoveries were calculated using both external0 2 4 6
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Figure 4 HPLC chromatogram of 20 lL injection of a solution c
Chromatograms of solutions of 85.2 lg/mL PTV obtained from Cabel
1 h) (B), base degradation (1 M NaOH/room temp for 1 h) (C) and o
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vealed satisfactory accuracy and precision as indicated from %
recovery, SD and RSD% values (Table 3). The resolution and
quantiﬁcation of PTV in its complex syrup dosage form with-
out any interference from the inactive ingredients can be con-
sidered as clear evidence for the speciﬁcity of the proposed
method.
A reference HPLC method was adopted for the determina-
tion of PTV in its commercial product (Do¨nmez et al., 2011).
Recovery data obtained from the developed HPLC method
were statistically compared with those of the reference method
using the Student’s t- and the variance ratio F-tests. In both
tests, the calculated values did not exceed the theoretical ones
at the 95% conﬁdence level which indicated that there were no
signiﬁcant differences between the recoveries obtained from
both methods (Table 3). It is evident from these results that
the proposed method is applicable to the analysis of PTV in
its syrup commercial formulation with minimum sample prep-
aration and satisfactory level of accuracy and precision.min8 10 12
9 3 2012\85CAB000001.D)
min8 10 12 14
9 3 2012\85CAB-HCL000001.D)
ontaining 85.2 lg/mL PTV obtained from Cabella syrup (A).
la syrup after exposure to acid degradation (1 M HCl/100 C for
xidative degradation (5% H2O2/80 C for 1 h) (D).
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Fig. 4 (continued)
Table 3 Analysis of PTV in its pharmaceutical preparation (Cabella syrup) by the proposed HPLC-DAD method and the reference
method.
External standard Reference methodc Standard addition
% Recovery ± SDa 99.16 ± 0.87 98.72 ± 0.96 99.49 ± 1.06
RSD%b 0.88 0.97 1.07
t 0.75
F 1.23
Theoretical values for t and F at P= 0.05 are 2.31 and 6.39, respectively.
a Mean ± standard deviation for ﬁve determinations.
b % Relative standard deviation.
c Do¨nmez et al. (2011).
8 D.A. Gawad, T.S. Belal3.4. Forced-degradation and stability-indicating aspects
Forced degradation studies help in identiﬁcation of the likely
degradation products of a drug substance, which can in turn
help in establishing the degradation pathways and the intrinsic
stability of the molecule and validate the stability-indicatingPlease cite this article in press as: Gawad, D.A., Belal, T.S. HPLC-DAD sta
degradation kinetics and assay of syrup dosage form. Arabian Journal ofpower of the proposed analytical procedure (Klick et al.,
2005). Also, forced degradation studies are useful when the de-
graded products or impurities are unknown or not available
(Klick et al., 2005). Forced degradation experiments were car-
ried out on PTV standard solutions in order to produce the
possible relevant degradation products and test theirbility indicating determination of pentoxyverine citrate. Application to
Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.11.023
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Figure 5 Kinetic study of the acid-induced degradation of PTV
at different temperatures.
HPLC-DAD stability indicating determination of pentoxyverine citrate 9chromatographic behavior using the developed method.
Hydrolytic, using strong acidic (1 M HCl) and strong basic
(1 M NaOH) media, oxidative (5% H2O2) and dry heat degra-
dation experiments were conducted, and the resulting chro-
matograms were compared with that obtained from standard
untreated solution of the drug (Fig. 2A).
No signs of degradation of PTV could be observed in 1 M
HCl medium at room temperature for 24 h; however, about
37% decrease in peak area as well as the appearance of a deg-
radation product peak at 11.03 min were clearly noticed after
heating with 1 M HCl at 100 C for 1 h (Fig. 2B). On the other
hand, PTV was susceptible to degradation by strong alkali at
room temperature. Treatment of PTV with 1 M NaOH and
keeping the solution at room temperature for 1 h resulted in
about 26% degradation and the appearance of the same previ-
ously mentioned degradation peak at 11.03 min (Fig. 2C).
Being an ester, PTV is expected to hydrolyze in both acidic
and basic media with the formation of the hydrolysis product
(1-phenylcyclopentanecarboxylic acid) which appears as a
common degradation peak at 11.03 min. Another extra peak
at 14.54 min appears only in the chromatograms of basic deg-
radation. This peak shows an absorption spectrum which is
very similar to that of the intact drug. This suggests that the
drug chromophore was not altered, and this impurity is prob-
ably produced from a reaction in the side chain. Further inves-
tigation revealed that this extra peak appears only when the
solution contains methanol (the solvent used for preparation
of PTV stock), while aqueous PTV solutions does not produce
this extra peak. This can be explained by the in situ formation
of the methyl ester of the hydrolysis product (1-phenylcyclop-
entanecarboxylic acid). This esteriﬁcation reaction can occur
as an artifact reaction when acid/base hydrolysis reactions
are performed using an alcohol co-solvent system such as
methanol (Baertschi, 2005). This side reaction does not occur
in acid degradation solutions, simply because acid hydrolysis
is initiated only at high temperature (100 C) where methanol
evaporates and does not remain in the solution.
PTV was found stable to oxidative degradation at room
temperature after 24 h, however, about 7% decrease in peak
area as well as the appearance of a degradation product peak
at 7.35 min were obviously detected after heating with 5%
H2O2 at 80 C for 1 h (Fig. 2D). Resolution between the peaks
of PTV and the oxidative degradation product at 7.35 min was
found to be 2.95. Hydrogen peroxide reacts with tertiary
amines to form tertiary amine oxides (Baertschi, 2005). The
degradation peak at 7.35 min shows an absorption spectrum
which is identical to that of the intact drug. This implies that
the drug chromophore is not involved in the reaction with
H2O2, and the new peak is most likely for a side chain oxida-
tion product (e.g. N-oxide of the tertiary nitrogen of PTV).
Dry heat forced degradation of PTV revealed slight degrada-
tion of the drug after heating at 90 C for 12 h. After the spec-
iﬁed time, solutions were prepared from the powder, and main
peak appeared at its speciﬁc retention time with area about
90% of that of the standard of the same concentration (i.e.
about 10% degradation), additionally, two small extra peaks
were observed at 2.83 and 14.07 min (Fig. 2E).
Similar forced degradation experiments were carried out on
aliquots of the syrup dosage form. As mentioned earlier, a
hydrolysis product peak at 11.03 min could be seen in the chro-
matograms of the acid and base degradations (Fig. 4B and C).
Also, obvious changes were noticed for the inactive ingredientsPlease cite this article in press as: Gawad, D.A., Belal, T.S. HPLC-DAD sta
degradation kinetics and assay of syrup dosage form. Arabian Journal ofpeaks especially in acidic medium. These changes included de-
crease in the peak areas and the emergence of several new deg-
radation peaks at retention times: 2.98, 3.05, 3.65, 4.07 and
4.57 min (Fig. 4B and C). Oxidative degradation of the syrup
produced similar observations to those obtained with the stan-
dard PTV (lower peak area for the drug and the evolution of a
well resolved degradation product peak at retention time of
7.30 min), besides, no signs of change could be seen for the
inactive ingredients peaks at 5.44, 7.43 and 10.11 min.
Fig. 4D shows the chromatogram of the dosage form solution
after treatment with 5% H2O2/80 C for 1 h.
It is noteworthy to mention that peak purity test results ob-
tained from the diode-array detector (DAD) conﬁrm that PTV
peak was homogenous and pure in all the analyzed samples
subjected to forced degradation conditions.
3.5. Degradation kinetics
The kinetics of acidic hydrolysis of PTV was investigated in
1 M HCl at different temperatures (70, 80 and 100 C) while
basic hydrolysis was studied in NaOH solutions of different
strengths (0.1, 0.5 and 1.0 M) at room temperature. Since the
decomposition rate of PTV at lower strengths of HCl and/or
at room temperature was too slow to obtain reliable kinetic
data, solutions of 1 M HCl at elevated temperatures were used
to investigate the acidic hydrolysis kinetics. However, signiﬁ-
cant basic hydrolysis of PTV could be observed at a faster rate
compared with that of acidic hydrolysis. Thus milder condi-
tions of NaOH strength at room temperature were applied
for basic hydrolysis kinetic study.
3.5.1. Acidic hydrolysis
A regular decrease in the concentration of PTV with increasing
time intervals was observed especially at 100 C. At the se-
lected temperatures (70, 80 and 100 C), the degradation pro-
cess followed pseudo-ﬁrst order kinetics (Fig. 5). From the
slopes of the straight lines, it was possible to calculate the cor-
responding degradation rate constants and half lives (t1/2) at
each temperature, based on the equation (Maher and Belal,
2012):
LogC ¼ logC0 Kt=2:303 ð1Þ
where the slope of the line = K/2.303, C and C0 are the drug
concentrations measured at a given time t and at zero time,bility indicating determination of pentoxyverine citrate. Application to
Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.11.023
Table 4 Pseudo ﬁrst-order rate constants (K) and half lives
(t½) for the acidic and basic hydrolysis of PTV.
Temperature (C) K (h1) t ½ (h)
Acidic hydrolysis using 1 M HCl
100 0.4314 1.61
80 0.0624 11.11
70 0.0253 27.39
25 1.145 · 104 6052.40 (252 days)
NaOH strength (M) K (h1) t½ (h)
Basic hydrolysis at room temp
1.0 0.2724 2.54
0.5 0.1272 5.45
0.1 0.0330 21.00
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Figure 7 Kinetic study of the base-catalyzed hydrolysis of PTV
at different sodium hydroxide strengths.
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Figure 8 pH-rate proﬁle curve of PTV using Britton Robinson
buffer at 100 C.
10 D.A. Gawad, T.S. Belalrespectively and K is the rate constant. These values are
gathered in Table 4. Additionally, logK values were then plot-
ted against the reciprocals of the absolute temperature (1/T) to
construct the Arrhenius plot (Maher and Belal, 2012; Florence
and Attwood, 2006). Arrhenius equation was found to be:
logK ¼ 13:80 ð5286:84=TÞ ð2Þ
Arrhenius plot is presented in Fig. 6. The K25 is used as a
measure of the stability of the drug at room temperature.
The logK25 value can be obtained by extrapolation on the
Arrhenius plot as illustrated in Fig. 6, however, for a more
accurate result, it was calculated from Eq. (2) where the
logK25 = –3.9411, and therefore K25 had the value of
1.145 · 104 h1. Accordingly, it was found that half life-time
(t1/2) of PTV in 1 M HCl at room temperature is about
252 days (Table 4). It is clear from these results that PTV
can be considered stable at room temperature even in strong
acidic medium.
3.5.2. Basic hydrolysis
For each NaOH strength (0.1, 0.5 and 1.0 M), log concentra-
tion of intact PTV remaining was plotted against time
(Fig. 7) and it was found that the degradation followed pseudo
ﬁrst order kinetics. In each case, pseudo ﬁrst order rate con-
stants were calculated from the slopes of the corresponding
plot, Eq. (1). The corresponding (t1/2) values were also calcu-
lated and presented in Table 4.Please cite this article in press as: Gawad, D.A., Belal, T.S. HPLC-DAD sta
degradation kinetics and assay of syrup dosage form. Arabian Journal of3.5.3. pH-rate proﬁle study
The effect of different pH values on the degradation of PTV
was studied using Britton–Robinson buffer of pH values rang-
ing from 2 to 12 at 100 C for different time intervals. The
apparent ﬁrst order degradation rate constants were calculated
at each pH and plotted versus the pH values resulting in pH-
rate proﬁle curve (Fig. 8). Obviously, PTV hydrolyzes in alka-
line pH values faster than in acidic pH solutions. The lowest
degradation rate constant is within the pH range 4–6 at which
the drug solution is most stable.
4. Conclusion
This study described a simple, selective and reliable HPLC-
DAD procedure for the assay of pentoxyverine citrate in its
complex pharmaceutical dosage form (syrup). Simplicity was
illustrated by the minimum requirement of organic solvents
since water was used as a solvent for the preparation of work-
ing and sample solutions. This suggests that the proposed
method is cost-effective and environment-friendly. To our
present knowledge, no attempts have been made yet to develop
a comprehensive stability indicating assay procedure for pent-
oxyverine in bulk form and in pharmaceutical formulations by
any analytical methodology. A signiﬁcant advantage in the
study is the separation of the analyte from dosage formbility indicating determination of pentoxyverine citrate. Application to
Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.11.023
HPLC-DAD stability indicating determination of pentoxyverine citrate 11excipients as well as from several degradation peaks obtained
by the hydrolytic, oxidative and dry heat forced-degradation
experiments. The chemical structures of the hydrolytic and oxi-
dative degradation peaks were proposed based on their
absorption spectra obtained from DAD. Reliability was guar-
anteed by testing the various validation parameters of the
method and the successful application to syrup dosage form.
The described method is superior to the previously reported
HPLC-DAD method for the assay of pentoxyverine in syrup
(Do¨nmez et al., 2011). The proposed method made use of
DAD as a tool for peak identity and purity conﬁrmation; how-
ever, it can be adapted to conventional HPLC–UV detection
which is the most popular in quality control laboratories. Fi-
nally, the proposed method was successfully applied to study
the kinetics of the acidic and basic degradation processes of
pentoxyverine and to derive the pH-rate proﬁle curve for the
drug.
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